• Exchange: Venture
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

DiaMedica Inc

+ Add to Watchlist

DMA:CN

0.6100 CAD 0.0100 1.61%

As of 14:56:59 ET on 07/31/2014.

Snapshot for DiaMedica Inc (DMA)

Open: 0.6100 Day's Range: 0.5800 - 0.6100 Volume: 84,900
Previous Close: 0.6200 52wk Range: 0.5400 - 1.4900 1-Yr Rtn: -41.90%

Stock Chart for DMA

No chart data available.
  • DMA:CN 0.6100
  • 1D
  • 1M
  • 1Y
0.6200
Interactive DMA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DMA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPTSX -
Earnings Per Share (CAD) (ttm) -0.1300
Est. EPS (CAD) (12/2014) -0.0800
Est. PEG Ratio -
Market Cap (M CAD) 37.84
Shares Outstanding (M) 62.03
30 Day Average Volume 22,338
Price/Book (mrq) 20.3254
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DMA

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for DMA

Diamedica Inc. is a biotechnology company focused on the development of treatments for Type 2 diabetes.

Rick PaulsPresident/CEOJohn SavageChief Financial Officer
James T ParsonsVP:Finance/SecretaryMark S WilliamsVP:Research
More Company Profile & Key Executives for DMA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil